Navigation Links
Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases
Date:7/7/2009

ommercial success of our existing products. Our stock price may be affected by actual or perceived market opportunity, competitive position, and success or failure of our products or product candidates. Further, the discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations.

The scientific information discussed in this news release related to our product candidates is preliminary and investigative. Such product candidates are not approved by the U.S. Food and Drug Administration (FDA), and no conclusions can or should be drawn regarding the safety or effectiveness of the product candidates. Only the FDA can determine whether the product candidates are safe and effective for the use(s) being investigated. Further, the scientific information discussed in this news release relating to new indications for our products is preliminary and investigative and is not part of the labeling approved by the U.S. Food and Drug Administration (FDA) for the products. The products are not approved for the investigational use(s) discussed in this news release, and no conclusions can or should be drawn regarding the safety or effectiveness of the products for these uses. Only the FDA can determine whether the products are safe and effective for these uses. Healthcare professionals should refer to and rely upon the FDA-approved labeling for the products, and not the information discussed in this news release.

ZOMETA is a registered trademark of Novartis Oncology.

*Editors Note: The FDA has provisionally approved the trade name Prolia(TM) for the proposed indications of treatment and prevention of osteoporosis in postmenopausal women, and treatment and prevention of bone loss in patients undergoing hormone ablation for non-metastatic prostate or breast
'/>"/>

SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Thiarabine Demonstrates a Reduction of Both Inflammatory and Erosive Disease Parameters in Rheumatoid Arthritis
2. Vantia Therapeutics Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia
3. Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R)
4. Study Demonstrates Efficacy of Pitavastatin in Elderly Patients
5. Semafores SF1126, a Vascular Targeted Pan-PI3K/mTOR Inhibitor, Is Well Tolerated and Demonstrates Activity in Phase I Solid Tumor Patients
6. Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results
7. Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen
8. ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients
9. Study Demonstrates Restylane(R) Effect Lasted 18 Months in 97% of Patients With One Repeat Injection
10. ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients
11. Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/rd24gk/chromatography ) ... (Instruments and Reagents) Global Market - Forecast to ... Chromatography is an analytical technique, a method of ... mixture by differential movement through a two phase ... chromatography as an esoteric art, which mainly involves ...
(Date:5/6/2015)... 06, 2015 Research and Markets ... the "Asia-Pacific Internal Trauma Fixation Devices Market ... Forecast To 2019" report to their offering. ... market is estimated to grow at a CAGR ... as technological advancement, rising incidences of road accidents, ...
(Date:5/6/2015)... 3D Communications announced today ... helping pharmaceutical companies communicate the value of their ... The newly expanded 3D Market Access and ... companies develop and deliver their "Value Story". It will ... critical stakeholders earlier in the "innovation-to-market" timeline, and ...
Breaking Medicine Technology:Global Chromatography (Instruments and Reagents) Market 2015 - Forecasts to 2019 2Asia-Pacific Internal Trauma Fixation Devices (Internal Trauma Fixation Plates, Screws, Rod Wires & Pins, Fusion Nails) Market 2015 23D Communications Expands Market Access and Reimbursement Communications Services for Pharmaceutical Companies 23D Communications Expands Market Access and Reimbursement Communications Services for Pharmaceutical Companies 3
... Md., Aug. 1, 2011 /PRNewswire-USNewswire/ – CoMeD ... Nations Environment Programme (UNEP) distributed a revised ...  Advocates for mercury-free drugs were gratified to see pharmaceuticals ... the proposed treaty. The Coalition for ...
... 2011 Reportlinker.com announces that a new ... catalogue: Patient Self-Monitoring: Devices, ...   http://www.reportlinker.com/p0581171/Patient-Self-Monitoring-Devices-Markets-Players-and-Prospects .html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic ... monitor their own serum levels is deemed ...
Cached Medicine Technology:Global Mercury Treaty May Include Ban on Mercury in Medicine 2Global Mercury Treaty May Include Ban on Mercury in Medicine 3Patient Self-Monitoring: Devices, Markets, Players and Prospects 2Patient Self-Monitoring: Devices, Markets, Players and Prospects 3
(Date:5/6/2015)... (PRWEB) May 06, 2015 TMG Health, ... to the Medicare Advantage, Medicare Part D and Managed ... Continuity and Resilience Team category at the BCI North ... Institute to recognize the outstanding contribution of business continuity ... North America Region, including the USA and Canada. The ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 “ SideChef ” was ... a look at the latest and coolest applications on the market ... and technology expert, conducted the app review and shared with viewers ... in the day when to be a good navigator people had ... out and now everyone is a master navigator. Well what if ...
(Date:5/6/2015)... 06, 2015 Marketing Maven ... international water, sanitation and hygiene nonprofit by GuideStar’s Philanthropedia. ... the world and it brings our agency great joy ... Marketing Maven. “The ongoing relationship between WaterAid ... people to learn about and support the nonprofit as ...
(Date:5/6/2015)... Anitha Nallari, MD has joined Shakir ... in Columbus, OH. Dr. Nallari will see patients with ... breast cancer, lung cancer, GI and gallbladder cancer, head and ... hematology. , Dr. Anitha Nallari is Board Certified ... Board of Internal Medicine. She completed her medical education in ...
(Date:5/6/2015)... May 06, 2015 Vancouver Chiropractic ... shared their new blog containing the Canadian Physical ... the Canadian Society for Exercise Physiology (CSEP). Since ... activity, health and fitness research and personal training ... exercise are highly beneficial and a rich resource ...
Breaking Medicine News(10 mins):Health News:TMG Health Recognized by the Business Continuity Institute 2Health News:TMG Health Recognized by the Business Continuity Institute 3Health News:An Application to Guide Users through Recipes Was Featured on NewsWatch Television 2Health News:Marketing Maven Expands Partnership with the #1 Ranked International Water, Sanitation and Hygiene Nonprofit 2Health News:Marketing Maven Expands Partnership with the #1 Ranked International Water, Sanitation and Hygiene Nonprofit 3Health News:New Oncologist to Join Hematology Oncology Consultants, Inc. 2Health News:New Oncologist to Join Hematology Oncology Consultants, Inc. 3Health News:Vancouver Chiropractor Shares Canadian Physical Activity and Sedentary Behavior Guidelines by CSEP in New Blog 2
... speaks to the American Medical Association (AMA) today addressing concerns ... from coast to coast, is listening. "A ... support a public health insurance, option. Since the AMA bills ... insurance stance, the AMA is fostering the notion that a ...
... , COMPREHENSIVE CARE FOR WOMEN OVER THEIR LIFESPAN COULD EASE ... 15 Delivering care for women with chronic illness costs ... according to a new study. It makes the case ... their lifespan can ultimately yield large cost savings while greatly ...
... , FORT WORTH, Texas, June 15 Female caregivers of African ... human papillomavirus (HPV), according to a new study by the Center ... Fort Worth, Texas. , , The HPV Vaccine Acceptability Study ... , ...
... help others with mild memory loss, study finds, , ... the chance of developing Alzheimer,s disease among those already ... the drug donepezil (Aricept), commonly prescribed for people with ... disease, the study also found. , The findings are ...
... French . , Montreal, 15th June 2009 ... of the 2009 Investigators in the Pathogenesis of Infectious Disease ... recipients granted $500,000 over a 6-year period for her research ... are studying how the body fights infections," says Dr. Saleh, ...
... tools help Highmark members navigate health insurance , ... health care system and administrative efficiencies are fundamental elements ... in Washington, DC. New tools from Highmark to conduct ... driving collaboration and streamlining medical claims processing right in ...
Cached Medicine News:Health News:Indiana U. expert says nation's physicians support national health insurance 2Health News:New Report Emphasizes Critical Role of Including Early and Preventative Care for Women in Health Care Reform 2Health News:HPV Vaccine Acceptability Study Announces Results 2Health News:HPV Vaccine Acceptability Study Announces Results 3Health News:Drug May Stem Slide Into Alzheimer's for Some 2Health News:MUHC researcher awarded $500,000 to study pathogenesis of infectious disease 2Health News:Rollout of New Health Care Provider Tools Creates Meaningful Transactions to Streamline Medical Claims 2Health News:Rollout of New Health Care Provider Tools Creates Meaningful Transactions to Streamline Medical Claims 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: